Amarin (AMRN -0.5%) says the U.S. Patent and Trademark Office gave a Notice of Allowance for two additional Marine Patent Applications that would protect Vascepa into 2030. The new notice comes on the back of yesterday's announcement that it had received a similar notification for its Vascepa patent titled "Method of Treating Hypertriglyceridemia." MKM Partners notes the significance of these patents, saying they're "clearly important for AMRN to secure a partnership or acquisition."
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Feb 25, 2015)
at Zacks.com (Feb 23, 2015)
at Benzinga.com (Jan 13, 2015)
at CNBC.com (Feb 28, 2014)
at MarketWatch.com (Jan 21, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs